(English) GT Molecular launches two highly sensitive tests for the dangerous UK Variant of SARS-CoV-2 (B.1.1.7)

FORT COLLINS, Colo., Jan. 12, 2021 /PRNewswire/ — GT Molecular, a rapidly expanding molecular diagnostics biotech, has launched two highly sensitive tests for the dangerous UK Variant of SARS-CoV-2 (B.1.1.7).  These novel assays build upon GT Molecular’s clinical background and technology for highly…